Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients. International Journal of Research in Clinical and Hospital Pharmacy, [S. l.], v. 2, n. 1, p. 1–4, 2019. Disponível em: https://rubatosis.org/journals/index.php/ijrhcp/article/view/144.. Acesso em: 19 apr. 2025.